- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02340039
Effects of Fruit Extracts on Glycaemia: The GLU-FRU Study (GLU-FRU)
The Acute Effects of Blackcurrant and Apple Extracts on Postprandial Glycaemia: a Randomised Controlled Trial. The GLU-FRU Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Introduction:
Diets with a high glycaemic load (a measure of the overall blood glucose-raising effect of a serving of a food) and containing high amounts of non-milk extrinsic sugars may contribute towards increased risk of developing type 2 diabetes (T2D). Raised blood glucose levels can lead to adverse modifications to functional proteins within the body and eventually lead to the development of T2D. Large peaks in blood glucose after a meal are a risk factor for T2D, and therefore it is desirable to consume a diet that will allow more gradual rises in blood glucose levels after meals. Fruit polyphenols may help to control glycaemia following a carbohydrate meal or beverage. Possible mechanisms include inhibition of intestinal enzymes and inhibition of intestinal glucose absorption by decreasing SGLT1/GLUT2 transport activity. The scientific literature also suggests that foods rich in polyphenols exert beneficial effects on risk factors of cardiovascular disease such as hypertension, lipid metabolism and vascular function.
Study Design:
A randomised, controlled, double-blind, cross-over study will be conducted. Subjects will receive combined blackcurrant and apple polyphenols, apple polyphenols only or placebo in random order at 3 separate study visits immediately before a high-carbohydrate meal. Seven days wash-out period will be required between study days.Standardised diet and exercise advice will be given prior to the visit. Subjects will arrive on each study visit between 09.00 and 10.00 h, after a 12 h overnight fast. They will then be cannulated in a forearm vein and baseline fasting blood samples will be taken in duplicate. All test drinks will be blended to be equal in volume, macronutrient and energy content. Fruit extracts instead of whole fruits will be administered to avoid the confounding effect of fruit fibre/viscosity on gastric emptying rate. Following consumption of the test drink, the high carbohydrate meal (starch and sucrose) will be served (white bread with apricot jam). Outcome variables will be measured postprandially until 120 min post-meal.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
England
-
London, England, United Kingdom, W3 7LR
- Metabolic Research Unit at King's College London. Franklin-Wilkins Buiding. Waterloo Campus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age: 20-60 y
- Male and female (post-menopausal only)
- Healthy (free of diagnosed diseases in the exclusion criteria)
- BMI 18-35 kg/m2
- Able to understand the information sheet and willing to comply with study protocol
- Able to give informed written consent
Exclusion Criteria:
- Those diagnosed with Phenylketonuria (PKU),
- Those with known or suspected food intolerances, allergies or hypersensitivity
- Women who are known to be pregnant or who are intending to become pregnant over the course of the study
- Women who are breast feeding
- Participation in another clinical trial
- Those who have donated blood within 3 months of the screening visit and participants for whom participation in this study would result in having donated more than 1500 millilitres of blood in the previous 12 months.
- Those with Full Blood Counts and Liver Function test results outside of the normal range (see table 1 below).
- Pre-menopausal women due to the potential influence of cyclical changes in reproductive hormones on insulin sensitivity
- Current smokers, or reported giving up smoking within the last 6 months
- History of substance abuse or alcoholism
- Reported history of CVD, diabetes (or fasting glucose ≥ 7.1 mmol/L), cancer, kidney, liver or bowel disease, gastrointestinal disorder or use of drug likely to alter gastrointestinal function
- Unwilling to restrict consumption of specified high polyphenol foods for 24 h before the study
- Weight loss >3kg in preceding 2 months and body mass index <18 or >35 kg/m2
- Blood pressure ≥160/100 mmHg
- Total cholesterol ≥ 7.5 mmol/L; fasting triacylglycerol concentrations ≥ 5.0 mmol/L
- Medications that may interfere with the study such as alpha-glucosidase inhibitors (acarbose: Glucobay), insulin-sensitising drugs (metformin: Glucophage, Glucophage SR, Eucreas, Janumet; thiazolidinediones: Actos, Competact), sulfonylureas (Daonil, Diamicron MR, Glibenese, Minodiab, Amaryl Tolbutamide), and lipid-lowering drugs (statins, nicotinic acid, colestyramine anhydrous, ezetimibe, fibrates). Other medications should be reviewed by medical representative from KCL on a case by case basis.
- Nutritional supplements that may interfere with the study such as higher dose vitamins/minerals (>200% RNI), B vitamins, Vitamin C, calcium, copper, chromium, iodine, iron, magnesium, manganese, phosphorus, potassium and zinc. Subjects already taking vitamin or minerals at a dose around 100% or less up to 200% of the RNI, or evening primrose/algal/fish oil supplements will be asked to maintain habitual intake patterns, ensuring that they take them every day and not sporadically. They will be advised not to stop taking supplements or start taking new supplements during the course of the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Blackcurrant &Apple
600 mg blackcurrant anthocyanins + 600 mg apple polyphenols delivered in a low sugar fruit drink
|
Drinks will be delivered in random order at 3 separate study visits immediately before a high-carbohydrate meal.
Seven days wash-out period will be required between study days.
|
Experimental: Apple
1200 mg apple polyphenols delivered in a low sugar fruit drink
|
Drinks will be delivered in random order at 3 separate study visits immediately before a high-carbohydrate meal.
Seven days wash-out period will be required between study days.
|
Placebo Comparator: Control drink
No polyphenols delivered in a low sugar fruit drink
|
Drinks will be delivered in random order at 3 separate study visits immediately before a high-carbohydrate meal.
Seven days wash-out period will be required between study days.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postprandial glycaemia
Time Frame: baseline and 10, 20, 30, 45, 60, 75, 90 and 120 min following the test drink.
|
Peak postprandial plasma glucose concentrations (Cmax) t +0-30 min and change from baseline data and areas over baseline t+0-30 min and t+0-120 min
|
baseline and 10, 20, 30, 45, 60, 75, 90 and 120 min following the test drink.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postprandial insulinaemia
Time Frame: baseline and 10, 20, 30, 45, 60, 75, 90 and 120 min following the test drink.
|
Peak postprandial insulin concentrations (Cmax) t +0-30 min and change from baseline data and areas over baseline t+0-30 min and t+0-120 min
|
baseline and 10, 20, 30, 45, 60, 75, 90 and 120 min following the test drink.
|
Postprandial glucose-dependent insulinotropic polypeptide (GIP) concentrations
Time Frame: baseline and 10, 20, 30, 45, 60, 75, 90 and 120 min following the test drink.
|
Peak postprandial GIP concentrations (Cmax) t +0-30 min and change from baseline data and areas over baseline t+0-30 min and t+0-120 min
|
baseline and 10, 20, 30, 45, 60, 75, 90 and 120 min following the test drink.
|
Postprandial glucagon-like peptide-1 (GLP-1) concentrations
Time Frame: baseline and 10, 20, 30, 45, 60, 75, 90 and 120 min following the test drink.
|
Peak postprandial GLP-1 concentrations (Cmax) t +0-30 min and change from baseline data and areas over baseline t+0-30 min and t+0-120 min
|
baseline and 10, 20, 30, 45, 60, 75, 90 and 120 min following the test drink.
|
Blood pressure
Time Frame: baseline and 60, 90 and 120 min following the test drink.
|
Change in the blood pressure after consumption of test drink
|
baseline and 60, 90 and 120 min following the test drink.
|
Vascular function (Digital Volume Pulse; DVP)
Time Frame: baseline and 60, 90 and 120 min following the test drink.
|
Change in the tone of larger arteries (stiffness index) and small to medium-sized arteries (reflection index).
|
baseline and 60, 90 and 120 min following the test drink.
|
Plasma non-esterified fatty acids (NEFA)
Time Frame: baseline and 10, 20, 30, 45, 60, 75, 90 and 120 min following the test drink.
|
Peak postprandial NEFA concentrations (Cmax) t +0-30 min and change from baseline data and areas over baseline t+0-30 min and t+0-120 min
|
baseline and 10, 20, 30, 45, 60, 75, 90 and 120 min following the test drink.
|
Plasma triglycerides (TAG)
Time Frame: baseline and 10, 20, 30, 45, 60, 75, 90 and 120 min following the test drink.
|
Peak postprandial TAG concentrations (Cmax) t +0-30 min and change from baseline data and areas over baseline t+0-30 min and t+0-120 min
|
baseline and 10, 20, 30, 45, 60, 75, 90 and 120 min following the test drink.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Wendy L Hall, Dr, King's College London
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GF2015
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postprandial Hyperglycemia
-
San Diego State UniversityRecruitingPostprandial Hyperglycemia | Postprandial Glycemic Response | Postprandial InsulinUnited States
-
University of LeedsCompletedEffect of Food on Postprandial HyperglycemiaUnited Kingdom
-
San Diego State UniversityCompletedPostprandial Hyperglycemia | Postprandial InsulinUnited States
-
Clinica Universidad de Navarra, Universidad de...CompletedLipid Profile | Hyperglycemia, Postprandial | Feeding Behaviors | Antioxidant | PostprandialSpain
-
Loughborough UniversityUniversity of BedfordshireCompletedPostprandial HyperglycemiaUnited Kingdom
-
Addis Ababa UniversityCompletedHyperglycemia, Postprandial
-
University of Eastern FinlandFinnsugar LtdCompletedHyperglycemia, PostprandialFinland
-
Harokopio UniversityNational and Kapodistrian University of AthensCompleted
-
University of SharjahCompletedPostprandial HyperglycemiaUnited Arab Emirates
-
Egas Moniz - Cooperativa de Ensino Superior, CRLCompletedHyperglycemia, PostprandialPortugal
Clinical Trials on Polyphenols
-
Technical University of MunichCompletedHeart Failure | Inflammation | Sudden Cardiac DeathGermany
-
University Hospital, Strasbourg, FranceTerminated
-
University of California, Los AngelesCompletedType II Diabetes MellitusUnited States
-
King's College LondonDIANA FoodCompletedPrevention of HyperglycaemiaUnited Kingdom
-
Northumbria UniversityThe New Zealand Institute for Plant and Food ResearchCompleted
-
Centre Hospitalier Universitaire VaudoisUniversity of LyonUnknownObesity | DiabetesSwitzerland
-
Nutri & CoNot yet recruitingMicrobial Colonization
-
University of Roma La SapienzaPeruzzi MariangelaCompletedCardiovascular Diseases | Oxidative StressItaly
-
Universiti Putra MalaysiaRecruiting
-
University of ThessalyCompletedInflammation | Oxidative StressGreece